Company / Current Liabilities
AVADEL PHARMACEUTICALS PLC Current Liabilities History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$48.8M
FY2024
5-year range
$15.1M / $55.8M
FY2020-FY2024
Trend
+32.5%
vs FY2023
Sector context
#142 of 213
Health Care
What the data says
At $49M, AVADEL PHARMACEUTICALS PLC's current liabilities ranks #72 of 213 in the Health Care sector. Current Liabilities has fluctuated over the past 10 years, ranging from $15M in FY2020 to $87M in FY2017.
Based on SEC 10-K filings.
$49M in FY2024 with a 5-year CAGR of +6.3%.
Improved from $56M to $49M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +32.5%
- 5-Year CAGR
- +6.3%
- 10-Year CAGR
- -
Sector benchmark
#72 of 213 in Health CareTop 33% of 213This company $48.8M Sector average $1.6B
▼
-96.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.3%, indicating consistent growth.
- In FY2024, current liabilities increased 32.5% year-over-year.
- Ranks #142 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $48.8M | +32.5% |
| FY2023 | $36.9M | -33.9% |
| FY2022 | $55.8M | +165.7% |
| FY2021 | $21.0M | +39.0% |
| FY2020 | $15.1M | -58.0% |
| FY2019 | $36.0M | -6.3% |
| FY2018 | $38.4M | -55.6% |
| FY2017 | $86.5M | +38.6% |
| FY2016 | $62.4M | +38.0% |
| FY2015 | $45.2M | -36.1% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026